Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]
Front MicrobiolFrontiers Production Office.
europepmc +1 more source
Carbapenem resistance in a <i>Klebsiella quasipneumoniae</i> isolate resulting from production of CTX-M-33 and OmpK36 porin deficiency. [PDF]
Antimicrob Agents ChemotherFindlay J +5 more
europepmc +1 more source
Development of a Novel Stability Indicating HPLC Method for the Simultaneous estimation of Cefepime and Enmetazobactam in Dosage Form Using Response Surface Methodology [PDF]
H. Neelofar, D. Ranganayakulu
openalex +1 more source
Mechanism, Dynamics and Inhibition of Class A β-Lactamases through Computation and Experiment [PDF]
Beer, Michael
core
New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria. [PDF]
Antibiotics (Basel)Machado E, Sousa JC.
europepmc +1 more source
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach. [PDF]
Curr Opin Infect DisTiseo G, Galfo V, Falcone M.
europepmc +1 more source
Cefepime-Taniborbactam in Complicated Urinary Tract Infection [PDF]
Aleksandrovs Andrejs +15 more
core +1 more source
Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]
Front MicrobiolSartori M, Toppo S, Lavezzo E.
europepmc +1 more source
Cefepime Enmetazobactam: A Carbapenem Sparing Strategy Against ESBL Producing Enterobacterales
Stefy Baby +3 more
openalex +1 more source
Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]
Rev Esp QuimioterCandel FJ, Matesanz M.
europepmc +1 more source